Firering Strategic Minerals: From explorer to producer. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHikma Pharmaceuticals Share News (HIK)

Share Price Information for Hikma Pharmaceuticals (HIK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,977.00
Bid: 1,750.00
Ask: 2,100.00
Change: 0.00 (0.00%)
Spread: 350.00 (20.00%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 1,977.00
HIK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

BROKER RATINGS SUMMARY: JPMorgan Cuts Merlin To Underweight

Thu, 14th Jan 2016 09:43

LONDON (Alliance News) - The following shares received analyst recommendations Thursday morning and Wednesday:
----------
FTSE 100
----------
CITIGROUP RAISES SAINSBURY PRICE TARGET TO 275 (265) PENCE - 'NEUTRAL'
----------
CITIGROUP CUTS ANGLO AMERICAN PRICE TARGET TO 300 (400) PENCE - 'NEUTRAL'
----------
CITIGROUP CUTS RIO TINTO PRICE TARGET TO 2100 (2500) PENCE - 'BUY'
----------
CITIGROUP RAISES BHP BILLITON TO 'BUY' ('NEUTRAL') - PRICE TARGET 750 (850) PENCE
----------
MORGAN STANLEY RAISES BHP BILLITON PRICE TARGET TO 1040 (1010) PENCE - 'OVERWEIGHT'
----------
Deutsche Bank Upgrades Berkeley Group Holdings To Buy From Hold; Raises Price Target To 4,161p From 3,346p
----------
GOLDMAN CUTS MONDI PLC PRICE TARGET TO 1070 (1300) PENCE - 'SELL'
----------
JPMORGAN CUTS WOLSELEY PRICE TARGET TO 4150 (4650) PENCE - 'OVERWEIGHT'
----------
JPMORGAN CUTS WHITBREAD PRICE TARGET TO 4850 (5660) PENCE - 'OVERWEIGHT'
----------
BARCLAYS CUTS WHITBREAD PRICE TARGET TO 4600 (5200) PENCE - 'EQUAL WEIGHT'
----------
JPMORGAN CUTS MERLIN ENTERTAINMENTS TO 'UNDERWEIGHT' ('NEUTRAL') - TARGET 440 (450) PENCE
----------
JPMORGAN CUTS INTERCONTINENTAL HOTELS PRICE TARGET TO 2750 (2770) PENCE - 'NEUTRAL'
----------
JPMORGAN RAISES COMPASS GROUP PRICE TARGET TO 1235 (1165) PENCE - 'NEUTRAL'
----------
GOLDMAN CUTS SPORTS DIRECT PRICE TARGET TO 525 (725) PENCE - 'BUY'
----------
JEFFERIES CUTS HIKMA PHARMACEUTICALS PRICE TARGET TO 2555 (2615) PENCE - 'BUY'
----------
JEFFERIES RAISES GLAXOSMITHKLINE PRICE TARGET TO 1375 (1325) PENCE - 'HOLD'
----------
UBS CUTS OLD MUTUAL PRICE TARGET TO 210 (245) PENCE - 'BUY'
----------
UBS RAISES JOHNSON MATTHEY PRICE TARGET TO 2600 (2550) PENCE - 'NEUTRAL'
----------
UBS RAISES INTERTEK PRICE TARGET TO 3050 (2850) PENCE - 'BUY'
----------
UBS RAISES ASHTEAD GROUP PRICE TARGET TO 1100 (1050) PENCE - 'NEUTRAL'
----------
UBS CUTS SHELL PRICE TARGET TO 1800 (2050) PENCE - 'BUY'
----------
NOMURA CUTS SHELL B PRICE TARGET TO 1575 (1900) PENCE - 'BUY'
----------
UBS CUTS BP PRICE TARGET TO 375 (420) PENCE - 'BUY'
----------
NOMURA CUTS BP PRICE TARGET TO 350 (360) PENCE - 'NEUTRAL'
----------
UBS CUTS BG GROUP PRICE TARGET TO 1185 (1300) PENCE - 'BUY'
----------
NOMURA CUTS BG GROUP PRICE TARGET TO 1150 (1200) PENCE - 'BUY'
----------
SOCGEN RAISES PROVIDENT FINANCIAL PRICE TARGET TO 3170 (2990) PENCE - 'HOLD'
----------
BERENBERG RAISES STANDARD CHARTERED TO 'BUY' ('HOLD') - TARGET 750 (950) PENCE
----------
TRADERS: MACQUARIE CUTS HSBC TO 'NEUTRAL' ('OUTPERFORM')
----------
FTSE 250
----------
Numis Downgrades William Hill To Add From Buy, Target At 425p
----------
Cantor Ups JD Sports Fashion Target To 1,300p From 1,200p, Keeps Buy
----------
Investec Ups JD Sports Fashion Target To 1,280p From 1,100p, Keeps Buy
----------
N+1 Downgrades The Restaurant Group To Sell From Buy, Target At 550p
----------
PANMURE CUTS RESTAURANT GROUP PRICE TARGET TO 750 (770) PENCE - 'BUY'
----------
GOLDMAN CUTS DS SMITH PRICE TARGET TO 390 (430) PENCE - 'NEUTRAL'
----------
JPMORGAN CUTS SIG PRICE TARGET TO 150 (165) PENCE - 'NEUTRAL'
----------
JPMORGAN CUTS BOVIS HOMES PRICE TARGET TO 1200 (1300) PENCE - 'OVERWEIGHT'
----------
JPMORGAN RAISES THOMAS COOK PRICE TARGET TO 170 (165) PENCE - 'OVERWEIGHT'
----------
JPMORGAN RAISES BELLWAY PRICE TARGET TO 3300 (3050) PENCE - 'OVERWEIGHT'
----------
EXANE BNP CUTS HAYS PRICE TARGET TO 160 (180) PENCE - 'OUTPERFORM'
----------
CREDIT SUISSE RAISES ELEMENTIS TO 'OUTPERFORM' ('NEUTRAL') - TARGET 240 (255)P
----------
GOLDMAN CUTS TULLOW OIL TO 'BUY' ('CONVICTION BUY LIST') - TARGET 305 (351) P.
----------
UBS CUTS G4S PRICE TARGET TO 305 (335) PENCE - 'BUY'
----------
UBS CUTS COMPUTACENTER TO 'NEUTRAL' ('BUY') - TARGET 850 PENCE
----------
MAIN MARKET AND AIM
----------
PANMURE RAISES HILTON FOOD PRICE TARGET TO 625 (570) PENCE - 'BUY'
----------
Investec Ups Hilton Food Group Target To 596p From 474p, Keeps Buy
----------
Deutsche Bank Ups Ryanair Holdings Target To EUR17.60 From EUR14.80, Keeps Buy
----------
JPMORGAN CUTS FENNER PRICE TARGET TO 116 (124) PENCE - 'UNDERWEIGHT'
----------
N+1 Singer Cuts Goals Soccer Centres To Hold From Buy, Target At 150p
----------
PANMURE RAISES GEMFIELDS RESOURCES PRICE TARGET TO 64 (60) PENCE - 'BUY'
----------
PANMURE CUTS PETRA DIAMONDS PRICE TARGET TO 112 (135) PENCE - 'BUY'
----------
PANMURE CUTS GEM DIAMONDS PRICE TARGET TO 181 (185) PENCE - 'BUY'
----------
By Arvind Bhunjun; arvindbhunjun@alliancenews.com; @ArvindBhunjun

Copyright 2016 Alliance News Limited. All Rights Reserved.

More News
24 Feb 2022 10:31

TOP NEWS: Hikma Pharmaceutical records revenue growth and lifts payout

(Alliance News) - Hikma Pharmaceutical PLC on Thursday reported full-year revenue growth on a "strong" performance by its three business segments and lifted its shareholder payout.

Read more
24 Feb 2022 07:58

Hikma Pharmaceutical delivers year of 'solid growth' and 'strategic momentum'

(Sharecast News) - Drugmaker Hikma Pharmaceutical said on Thursday that it had delivered another successful year of "solid growth and continued strategic momentum", with both revenue and operating profits improving year-on-year.

Read more
24 Feb 2022 07:50

LONDON MARKET PRE-OPEN: Share buybacks for Lloyds Banking and Hikma

(Alliance News) - Stock prices in London are seen opening sharply lower, with the FTSE 100 called down almost 200 points, amid fear of a full-scale war in eastern Europe after Russia announced the beginning of a military operation in Ukraine.

Read more
17 Feb 2022 16:08

UK earnings, trading statements calendar - next 7 days

Friday 18 February  
NatWest Group PLCFull Year Results
Pod Point Group Holdings PLCFull Year Results
Segro PLCFull Year Results
TBC Bank Group PLCFull Year Results
Monday 21 February 
Bank of Cyprus Holdings PLCFull Year Results
Dechra Pharmaceuticals PLCHalf Year Results
Finsbury Food Group PLCHalf Year Results
Sylvania Platinum LtdHalf Year Results
Tristel PLCTrading Statement
Wilmington PLCHalf Year Results
Tuesday 22 February 
Antofagasta PLCFull Year Results
Bank of Georgia Group PLCFull Year Results
Benchmark Holdings PLCQ1 Results
Blancco Technology Group PLCHalf Year Results
Bluefield Solar Income Fund LtdHalf Year Results
Coca-Cola HBC AGFull Year Results
Hargreaves Lansdown PLCHalf Year Results
HSBC Holdings PLCFull Year Results (at 0400 GMT)
InterContinental Hotels Group PLCFull Year Results
Oxford Cannabinoid Technologies Holdings PLCHalf Year Results
Smith & Nephew PLCFull Year Results
Springfield Properties PLCHalf Year Results
Synectics PLCFull Year Results
Transense Technologies PLCHalf Year Results
Wednesday 23 February 
Aston Martin Lagonda Global Holdings PLCFull Year Results
Barclays PLCFull Year Results
Capital & Counties Properties PLCFull Year Results
CAP-XX LtdHalf Year Results
Georgia Capital PLCFull Year Results
International Personal Finance PLCFull Year Results
Irish Residential Properties REIT PLCFull Year Results
Metro Bank PLCFull Year Results
Hochschild Mining PLCFull Year Results
Photo-Me International PLCFull Year Results
Rio Tinto PLCFull Year Results
Seraphim Space Investment Trust PLCHalf Year Results
Ted Baker PLCTrading Statement
Unite Group PLCFull Year Results
Thursday 24 February 
Anglo American PLCFull Year Results
BAE Systems PLCFull Year Results
Centrica PLCFull Year Results
Conduit Holdings LtdFull Year Results
Derwent London PLCFull Year Results
Drax Group PLCFull Year Results
Genus PLCHalf Year Results
Hays PLCHalf Year Results
Hikma Pharmaceuticals PLCFull Year Results
Howden Joinery Group PLCFull Year Results
Inchcape PLCFull Year Results
Lloyds Banking Group PLCFull Year Results
Macfarlane Group PLCFull Year Results
Morgan Sindall Group PLCFull Year Results
Rathbone Group PLCFull Year Results
Ricardo PLCHalf Year Results
Rolls-Royce Holdings PLCFull Year Results
Serco Group PLCFull Year Results
Spectris PLCFull Year Results
St James's Place PLCFull Year Results
Tremor International LtdFull Year Results
WPP PLCFull Year Results
  
Copyright 2022 Alliance News Limited. All Rights Reserved.

Read more
9 Feb 2022 09:48

LONDON BROKER RATINGS: Barclays downgrades Chemring and boohoo

LONDON BROKER RATINGS: Barclays downgrades Chemring and boohoo

Read more
3 Feb 2022 09:12

Hikma completes acquisition of Teligent's Canadian assets

Hikma completes acquisition of Teligent's Canadian assets

Read more
17 Jan 2022 09:01

TOP NEWS: Hikma Pharmaceutical acquires Teligent for USD45.8 million

TOP NEWS: Hikma Pharmaceutical acquires Teligent for USD45.8 million

Read more
17 Jan 2022 09:00

TOP NEWS: Hikma Pharmaceutical acquires Teligent for USD45.8 million

TOP NEWS: Hikma Pharmaceutical acquires Teligent for USD45.8 million

Read more
17 Jan 2022 07:49

LONDON MARKET PRE-OPEN: Unilever sees good fit in GSK Consumer Health

LONDON MARKET PRE-OPEN: Unilever sees good fit in GSK Consumer Health

Read more
17 Jan 2022 07:08

Hikma buys Teligent Canadian assets for $47.75m

(Sharecast News) - Hikma Pharmaceuticals on Monday said it had agreed to buy the Canadian assets of Teligent for $45.75m after the US firm filed for Chapter 11 bankruptcy last year.

Read more
10 Jan 2022 07:44

LONDON MARKET PRE-OPEN: Plus500 hails 2021 and mulls new share buyback

LONDON MARKET PRE-OPEN: Plus500 hails 2021 and mulls new share buyback

Read more
10 Jan 2022 07:24

Hikma launches new US injectables unit

(Sharecast News) - Hikma Pharmaceuticals on Monday said it was expanding its injectables business with the launch of a new outsourced sterile compounding business in the US.

Read more
21 Dec 2021 15:55

Arecor flags milestone payment from Hikma in first half of next year

(Sharecast News) - Biopharmaceutical company Arecor Therapeutics updated the market on its ongoing exclusive agreement with Hikma Pharmaceuticals to co-develop a new, ready-to-use injectable medicine on Tuesday.

Read more
9 Dec 2021 09:25

Hikma adds two biosimilars to portfolio with Gedeon Richter agreement

Hikma adds two biosimilars to portfolio with Gedeon Richter agreement

Read more
9 Dec 2021 08:32

Hikma strikes exclusive license agreement with Richter for denosumab

(Sharecast News) - Drugmaker Hikma Pharmaceuticals has entered into an exclusive license agreement with Gedeon Richter to commercialise the latter's denosumab products in the US.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.